Therefore, Tregs mainly downregulate the quantity and activity of Teffs by secreting different soluble negative immune molecules and suppress the growth of Teffs and NKs by competing with and depleting IL-2, which can cause immune escape of tumor cells and induce drug resistance in AML. This evidence concerns the gene IL2 and neoplasm.